September 2025
1. DI LORENZO G, Verde A, Scafuri L, Baio R, et al
   Development and validation of the PREVES-HOR Questionnaire: a patient-reported measure of hormone-therapy-related quality of life in prostate-cancer patients undergoing androgen-deprivation therapy.
   Oncology. 2025 Sep 29:1-29. doi: 10.1159/000548317.
   

   >> Share

   
   July 2025
2. TAPIA-SALAS IA, Dorantes-Heredia R, Flores-Marinelarena RR, Moreno-Lopez R, et al
   Evaluation of HER2 expression in prostate cancer among Mexican patients.
   Oncology. 2025 Jul 14:1-16. doi: 10.1159/000547372.
   

   >> Share

   
   March 2025
3. CHEN J, Fu S, Yu J, Tang Q, et al
   Modified Glasgow prognostic score as a marker for predicting outcomes in patients with either bladder and prostate cancer : A systematic review and meta-analysis.
   Oncology. 2025 Mar 28:1-20. doi: 10.1159/000545001.
   

   >> Share

   
   January 2025
4. GUI Q, Wang X, Wu D, Guo Y, et al
   Constructing and Validating Models for Predicting Gleason Grade Group Upgrading Following Radical Prostatectomy in Localized Prostate Cancer: A Comparison between Machine Learning Algorithms and Conventional Logistic Regression.
   Oncology. 2025 Jan 24:1-15. doi: 10.1159/000543492.
   

   >> Share

   
   October 2024
5. NOVYSEDLAK R, Guney M, Al Khouri M, Bartolini R, et al
   The Immune Microenvironment in Prostate Cancer: A Comprehensive Review.
   Oncology. 2024 Oct 9:1-37. doi: 10.1159/000541881.
   

   >> Share

   
   August 2024
6. MASUDA R, Noguchi Y, Aizawa H, Yoshizawa S, et al
   Assessment of Cardiovascular Events Caused by New-Generation Androgen Receptor Pathway Inhibitors Used for Prostate Cancer: A Real-World Study in Japan.
   Oncology. 2024 Aug 14:1-9. doi: 10.1159/000540864.
   

   >> Share

   
   January 2024
7. SCHAULIN MS, Delouya G, Zwahlen D, Taussky D, et al
   Tracing the Evolution of Prostate Brachytherapy in the 20th Century.
   Oncology. 2024;102:283-290.
   

   >> Share

   
   December 2023
8. JI WT, Jin XF, Wang Y
   The rate of clinically significant prostate cancer on repeat biopsy after a diagnosis of atypical small acinar proliferation: A systematic review and meta-analysis.
   Oncology. 2023 Dec 7. doi: 10.1159/000535123.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share